3695.T GMO Product Platform JPX closes ¥1,989.00 02 Feb 2026: AI unit watched

The market closed with GMO Product Platform, Inc. (3695.T JPX) at ¥1,989.00 on 02 Feb 2026, up 2.05% from the prior session. 3695.T stock moved between ¥1,941.00 and ¥2,006.00 on light volume of 6,500 shares as investors positioned ahead of the 10 Feb 2026 earnings announcement. This note looks at valuation, AI-related growth drivers, technical signals, and Meyka AI forecasts to frame an actionable view for Japan market participants.

3695.T stock: daily price action and volumes

GMO Product Platform (3695.T) closed at ¥1,989.00, a ¥40.00 gain or 2.05% on the JPX session. Trading volume was 6,500 versus a 50-day average of 5,188.00, so activity was marginally above average. The intraday range, ¥1,941.00 to ¥2,006.00, shows intra-session buying near the close and support near the year low of ¥1,850.00.

3695.T stock: fundamentals and valuation

On fundamentals 3695.T stock reports EPS of ¥64.12 and a reported PE of 31.16 from the full quote, with a market cap of ¥8,797,441,752.00 and 4,403,124 shares outstanding. Price averages sit below 50-day and 200-day means at ¥2,090.52 and ¥2,324.73, signaling medium-term underperformance versus historical trend. Key ratios include PB 3.75, PS 1.40, and a current ratio of 2.01, indicating a conservative balance sheet with modest valuation premium versus Industrials peers (sector avg PE 18.09).

3695.T stock: AI segment and growth outlook

GMO Product Platform has repositioned toward AI-enabled audience research and automated data services after renaming to GMO Research & AI, Inc. in 2024. Revenue per share is ¥1,427.34 and net income per share ¥50.17, while long-term trends show five-year revenue per share growth near 52.93%. Analysts and investors will watch whether AI projects lift margins above the current operating margin of 7.28% and reverse recent EPS declines reported in 2024.

3695.T stock: technical indicators and market signals

Technical signals for 3695.T stock are mixed. RSI sits at 42.10, below neutral, while MACD histogram is -17.53, pointing to short-term bearish momentum. Bollinger Band middle is ¥2,137.45 and lower band ¥2,050.47, so price at ¥1,989.00 is trading below key moving averages and near the lower volatility bands. Watch RSI support and the upcoming earnings release as catalysts for directional confirmation.

Meyka AI rates 3695.T with a score out of 100 and model forecast

Meyka AI rates 3695.T with a score out of 100: the platform assigns a score 71.42 (Grade B+, Suggestion: BUY). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a monthly price of ¥2,496.64 and a yearly price of ¥2,683.62. Versus the current close of ¥1,989.00, the model implies an upside of 25.52% to the monthly figure and 34.93% to the yearly figure. Forecasts are model-based projections and not guarantees.

3695.T stock: risks, catalysts and investor strategy

Primary near-term catalyst is the earnings release on 10 Feb 2026, which could move shares if guidance or AI contract updates surprise. Risks include margin pressure noted in FY2024 and the stock’s premium PE relative to the Industrials sector average. For traders, consider event-driven exposure into earnings. For longer-term investors, weigh AI growth potential against a PE in the low 30s and limited free cash flow visibility.

Final Thoughts

3695.T stock closed the JPX session at ¥1,989.00 on 02 Feb 2026 with subdued volume and clear focus on the AI business ahead of earnings. The shares trade under the 50-day and 200-day averages, reflecting a pullback from the year high of ¥3,130.00 and signaling medium-term consolidation. Meyka AI’s model projects ¥2,683.62 over the next year, implying a 34.93% upside from today’s close; the monthly model target is ¥2,496.64 (implied 25.52% upside). Investors should balance the stock’s B+ (71.42) Meyka grade and the company’s solid balance sheet against elevated valuation metrics, including a reported PE of 31.16 and PB 3.75. Use the upcoming 10 Feb 2026 earnings release as a decision point: positive AI contract news can re-rate the stock, while weaker margins or guidance could extend the correction. Meyka AI provides this as data-driven market analysis and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.